Induced ketosis as a treatment for neuroprogressive disorders: food for thought?
In this article, Morris et al. (2020) explain the mechanisms by which induced ketosis might reduce mitochondrial dysfunction, inflammation, and oxidative stress in neuropsychiatric disorders, and may be able to ameliorate abnormal levels of molecules and signaling pathways that appear to contribute to the pathophysiology of disorders such as schizophrenia, bipolar disorder, and major depressive disorder. In addition, the authors examine the safety data relating to induced ketosis over the long term and discuss future study design. [NPID: mood disorders, psychiatric disorders, ketosis, ketones, ketogenic diet, keto, mitochondrial dysfunction, inflammation, oxidative stress, major depressive disorder, MDD, bipolar disorder, BD]
Year: 2020
Reference: Morris, G., Puri, B. K., Carvalho, A., Maes, M., Berk, M., Ruusunen, A., & Olive, L. (2020). Induced Ketosis as a Treatment for Neuroprogressive Disorders: Food for Thought?. The international journal of neuropsychopharmacology, 23(6), 366–384. https://doi.org/10.1093/ijnp/pyaa008
Related Studies
Research has been highly focused on the complex interactions that exist between the gut, the gut microbiota, and the central nervous system, thus associating the microbiome with disease pathogenesis, including that involving the central nervous system (CNS). Golofast and Vales (2020) therefore hypothesized that the gut microbiota may be linked with specific important stages in […]
Ghaderi et al. (2019) analyzed the effects of a novel combination of vitamin D and probiotics on metabolic and clinical symptoms of chronic schizophrenia. A total of 60 patients with schizophrenia took part in this study, of which half received a dose of either vitamin D3 (50,000 IU) every two weeks as well as 8 […]